P

Inventor

SCHARN DIRK

DE11 patents
⚠️ This page may combine multiple inventors who share the name “SCHARN DIRK”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

BOEHRINGER INGELHEIM INT

5 patents
US12064421B2Aug 20, 2024

Substituted 1H-pyrazolo[4,3-c]pyridines and derivatives as EGFR inhibitors

BOEHRINGER INGELHEIM INT0 citations49
US11174245B2Nov 16, 2021

Benzimidazole compounds and derivatives as EGFR inhibitors

BOEHRINGER INGELHEIM INT0 citations46
US11261184B2Mar 1, 2022

[1,6]naphthyridine compounds and derivatives as CDK8/CDK19 inhibitors

BOEHRINGER INGELHEIM INT0 citations44
US11608343B2Mar 21, 2023

Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors

BOEHRINGER INGELHEIM INT0 citations43
US11213520B2Jan 4, 2022

Phenylpyrazolylacetamide compounds and derivatives as CDK8/CDK19 inhibitors

BOEHRINGER INGELHEIM INT0 citations43

ZISCHINSKY GUNTHER

2 patents
US8927534B2Jan 6, 2015

Compounds for the inhibition of integrins and use thereof

ZISCHINSKY GUNTHER3 citations54
US8309735B2Nov 13, 2012

Heterocyclic compounds for the inhibition of integrins and use thereof

ZISCHINSKY GUNTHER2 citations54

SCHNATBAUM KARSTEN

1 patent
US8071810B2Dec 6, 2011

C5a receptor antagonists

SCHNATBAUM KARSTEN11 citations77

JERINI AG

1 patent
US7727960B2Jun 1, 2010

C5a receptor antagonists

JERINI AG4 citations54

JPT PEPTIDE TECHNOLOGIES GMBH

1 patent
US8029979B2Oct 4, 2011

Method for determining the substrate specificity of an enzyme

JPT PEPTIDE TECHNOLOGIES GMBH5 citations49

GIBSON CHRISTOPH

1 patent
US8410134B2Apr 2, 2013

8-oxy-quinoline derivatives as bradykinin B2 receptor modulators

GIBSON CHRISTOPH1 citations41